Medicare Enrolled
Dr. Armita Atashband, MD
Cardiovascular Disease · Humble, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Atashband from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Atashband? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Atashband
Dr. Armita Atashband is a cardiovascular disease in Humble, TX, with 17 years in practice. Based on federal Medicare data, Dr. Atashband performed 35,098 Medicare services across 5,882 unique beneficiaries.
Between the years covered by Open Payments, Dr. Atashband received a total of $11,196 from 47 pharmaceutical and/or device companies across 446 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Atashband is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice▲ Top 0% volume in TX$ $11,196 industry payments
Medicare Practice Summary
Medicare Utilization ↗35,098
Medicare services
Top 0% in TX for cardiovascular disease
5,882
Unique beneficiaries
$70
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,065 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) | 26,611 | $0 | $2 |
| Regadenoson injection (Lexiscan) for heart stress test | 3,065 | $43 | $292 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 785 | $55 | $185 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 774 | $608 | $910 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 756 | $1,958 | $6,005 |
| Office visit, established patient (30-39 min) | 504 | $96 | $283 |
| Electrocardiogram (EKG), 12-lead | 301 | $11 | $44 |
| Injection of drug or substance into vein | 264 | $31 | $102 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 243 | $144 | $509 |
| Ultrasound of both sides of head and neck blood flow | 180 | $146 | $520 |
| Blood draw (venipuncture) | 160 | $8 | $10 |
| Ct scan of blood vessels and grafts of heart with contrast | 114 | $218 | $942 |
| Basic metabolic blood panel | 93 | $8 | $28 |
| Ultrasound of leg arteries or artery grafts | 82 | $191 | $662 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 82 | $96 | $506 |
| Hospital follow-up visit, moderate complexity | 72 | $63 | $188 |
| Ct scan of blood vessels of chest with contrast | 68 | $166 | $789 |
| Magnesium level test | 67 | $7 | $21 |
| Lipid panel (cholesterol and triglycerides) | 65 | $13 | $42 |
| Ct scan of blood vessels of abdomen and pelvis with contrast | 59 | $321 | $1,049 |
| Liver function blood test panel | 57 | $8 | $28 |
| CT scan of chest, without contrast | 52 | $76 | $409 |
| Complete blood count (CBC) with differential | 49 | $8 | $24 |
| Chemical destruction of first incompetent vein of arm or leg using imaging guidance | 41 | $1,360 | $5,113 |
| Natriuretic peptide (heart and blood vessel protein) level | 41 | $38 | $104 |
| New patient office visit (45-59 min) | 41 | $109 | $425 |
| EKG interpretation and report | 33 | $6 | $22 |
| Ct scan of blood vessels of neck with contrast | 31 | $204 | $767 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 29 | $684 | $1,824 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 28 | $20 | $69 |
| Thyroid stimulating hormone (TSH) test | 27 | $16 | $56 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 27 | $90 | $378 |
| Unclassified drugs | 26 | $1 | $92 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 25 | $361 | $1,235 |
| Ct scan of heart structure with contrast | 24 | $164 | $645 |
| Comprehensive metabolic blood panel | 24 | $10 | $37 |
| Initial hospital admission, moderate complexity | 24 | $96 | $363 |
| Echocardiogram, transthoracic | 22 | $117 | $539 |
| Ct scan of abdominal aorta and both leg arteries with contrast | 21 | $217 | $840 |
| Injection of additional new drug or substance into vein | 21 | $13 | $42 |
| Blood creatinine level | 18 | $5 | $16 |
| Urea nitrogen level to assess kidney function, quantitative | 18 | $4 | $13 |
| Office visit, established patient (20-29 min) | 18 | $70 | $193 |
| Office visit, established patient, complex (40-54 min) | 18 | $84 | $378 |
| Prothrombin time test (blood clotting) | 13 | $4 | $16 |
| Coagulation assessment blood test, plasma or whole blood | 13 | $6 | $19 |
| Chest X-ray, 2 views | 12 | $28 | $87 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.1% high complexity
92.7% medium
7.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$11,196
Total received (2018-2024)
Avg $1,599/year across 7 years
Top 29% in TX for cardiovascular disease
47
Companies
446
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,099 (99.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$98 (0.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,748
2023$1,705
2022$1,910
2021$1,331
2020$1,154
2019$1,526
2018$1,822
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$1,418
Novartis Pharmaceuticals Corporation
$1,326
Abbott Laboratories
$948
Medtronic Vascular, Inc.
$572
Janssen Pharmaceuticals, Inc
$513
E.R. Squibb & Sons, L.L.C.
$453
Impulse Dynamics (USA) Inc.
$444
Tactile Systems Technology Inc
$440
Merck Sharp & Dohme LLC
$395
Amgen Inc.
$394
BOSTON SCIENTIFIC CORPORATION
$378
Bard Peripheral Vascular, Inc.
$294
BARD PERIPHERAL VASCULAR, INC.
$293
CVRx, Inc.
$273
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$265
Esperion Therapeutics, Inc.
$248
AstraZeneca Pharmaceuticals LP
$238
ABIOMED
$230
Amarin Pharma Inc.
$218
HeartFlow, Inc.
$214
PFIZER INC.
$187
Kowa Pharmaceuticals America, Inc.
$152
Novo Nordisk Inc
$126
Cardiovascular Systems Inc.
$124
Astellas Pharma US Inc
$121
Canon Medical Systems USA, Inc.
$99
SANOFI-AVENTIS U.S. LLC
$91
Biocompatibles, Inc.
$85
Kiniksa Pharmaceuticals International, plc
$76
Actelion Pharmaceuticals US, Inc.
$69
Bolton Medical Inc
$66
AtriCure, Inc.
$62
Medtronic, Inc.
$46
Regeneron Pharmaceuticals, Inc.
$38
InfoBionic, Inc
$36
Endologix LLC
$31
Merck Sharp & Dohme Corporation
$29
Lexicon Pharmaceuticals, Inc.
$29
Resmed Corp
$25
Boehringer Ingelheim Pharmaceuticals, Inc.
$25
Alnylam Pharmaceuticals Inc.
$24
GE HealthCare
$22
BIOTRONIK INC.
$22
Chiesi USA, Inc.
$15
Bayer HealthCare Pharmaceuticals Inc.
$14
LeMaitre Vascular, Inc.
$14
Becton, Dickinson and Company
$13
Top 3 companies account for 33.0% of total payments
Associated products mentioned in payments ›
AIR 11 · ARCTIC FRONT ADVANCE · AVVIGO Guidance System · Alto Abdominal Stent Graft System · Amplia MRI · Arcalyst · BRILINTA · Barostim Neo System · CAMZYOS · CARDIOMEMS · CHANTIX · CONFIRM RX · ClosureFast · Connectivity and Remote care · Corlanor · Coronary Orbital Atherectomy System · DIAMONDBACK PERIPHERAL · ELIQUIS · ENSITE · ENSITE PRECISION · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Ensite Cardiac Mapping System · FARXIGA · FFRct · FLEXITOUCH · Flexitouch Plus · GENERAL STRUCTURAL HEART · GUIDEZILLA · Impella · Inpefa · JARDIANCE · KENGREAL · Kerendia · LEQVIO · LEXISCAN · LIFESTENT · LIFESTREAM · LUTONIX · LifeVest · Livalo · MULTAQ · Merlin Connectivity and Remote · MoMe Kardia · NEXLETOL · NEXLIZET · ONPATTRO · OPSUMIT · OPTIMIZER · Optimizer · Optimizer Smart System · Ozempic · PET-CT SCANNER · PRALUENT · Pacemakers · Peripheral Orbital Atherectomy System · RESONATE · RESTOREFLO · Relay Grafts · Repatha · Resolute · RotarexS 6 F x 135 cm · STEGLATRO · SYNERGY · Saxenda · ULTRAVERSE · VARITHENA · VENASEAL · VENOVO · VERQUVO · VIGILANT · Vascepa · VenaSeal · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO · XIENCE SIERRA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $32 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
350
Per 100K population
7.4
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN NORTHEAST HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Atashband is a mixed practice specialist, with above-average Medicare volume (top 0% in TX), and low-engagement industry engagement, with 17 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Atashband experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Atashband performed 26,611 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Atashband receive payments from pharmaceutical companies?
Yes. Dr. Atashband received a total of $11,196 from 47 companies across 446 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Atashband's costs compare to other cardiovascular diseases in Humble?
Dr. Atashband's average Medicare payment per service is $70. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Atashband) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Humble
Browse cardiovascular diseases in Humble ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in TX
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in TX
Which TX cardiovascular diseases receive the most from drug and device companies.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology